Categories
Uncategorized

Pathobody Eurostars Project awarded April 2021

PubGene was awarded a Eurostars project together with AbSano B.V, Erasmus MC and GenXPro GmbH. The aim of the project is to develop a platform for the recovery of pathogen-specific antibody molecules from exposed patients for the purpose of generating high value monoclonal antibody leads. This will be done by combining of NGS, phage display, […]

Categories
Uncategorized

AntiSeptic – New Eurostars project awarded July 2022

PubGene was awarded a new Eurostars project with start date July 2022 together with Da Vinci laboratory solution B.V., Erasmus MC and Evosep Aps. In this project we will develop a technology platform for rapid identification of causative bacterial species in bloodstream infections (BSI/sepcis) by identifying their mechanisms of resistance (MoR). The product solution includes […]

Categories
Uncategorized

The ‘GlioPhos’ project

Glioblastoma is a highly heterogeneous tumour and patients with this disease have a poor prognosis. Partly because the tumour infiltrates the surrounding brain tissue, surgical removal of the tumour is often incomplete, so that it is usually necessary to give these patients an adjuvant treatment after surgery. In general, these treatments are not effective. Physiological […]

Categories
Uncategorized

Archive and Recent posts

Categories
Uncategorized

Dr. Jimita Toraskar Interviewed By The Future Of Health.Care Group

The futureofhealth.care is an online discussion platform for healthcare professionals. It identifies white space in the market so that promising start-up and healthcare industry can get actionable and early insights to make better decisions. Recently, the future of health.care group interviewed Dr. Jimita Toraskar, scientist at PubGene AS. She shared her views on how to […]

Categories
Uncategorized

We are hiring!

At PubGene AS, we are building Coremine Vitae, a new Digital Health solution for Personalized Medicine. Coremine Vitae empowers patients with cancer, autoimmune or neurodegenerative diseases to live longer and better lives by helping healthcare providers identify the most precise, effective, and evidence-based treatment options. Using our digital health solution we create the Coremine Vitae […]

Categories
Uncategorized

We are hiring!

Join us on our mission to make personalized medicine available to all. At PubGene AS, we are building Coremine Vitae, a new Digital Health solution for Personalized Medicine. Coremine Vitae empowers patients with cancer, autoimmune or neurodegenerative diseases to live longer and better lives by helping healthcare providers identify the most precise, effective, and evidence-based […]

Categories
Uncategorized

Why Google, When You Can Coremine – Lecture by Jimita Toraskar

Dr. Jimita Toraskar from PubGene AS was invited to participate in the International Lecture Series organized by Dr. Bhanuben Nanavati College of Pharmacy in Mumbai, India. As a part of this initiative, Dr. Jimita Toraskar (Scientist at PubGene AS) delivered a hands-on session titled, “Why Google when you can COREMINE” on September 27, 2020. She […]

Categories
Uncategorized

Dr. Jimita Toraskar interviewed by The Future of Health.care group

The futureofhealth.care is an online discussion platform for healthcare professionals. It identifies white space in the market so that promising start-up and healthcare industry can get actionable and early insights to make better decisions. Recently, the future of health.care group interviewed Dr. Jimita Toraskar, scientist at PubGene AS. She shared her views on how to […]

Categories
Uncategorized

Pubgene’s digital health COREMINE Vitae™ obtained CE-mark

PubGene’s digital health platform for personalised medicine, Coremine Vitae, obtained the CE-mark Class I Medical Device, ensuring that it complies with all the relevant Essential Requirements of the Medical Devices Directive – 93/42/EEC MDD and subsequent amendments.